ACIP opts to lift pause on Johnson & Johnson vaccine | CIDRAP

J&J vaccine is back. 

Benefits out weigh the risks. Single dose vaccine. 

Highly effective - 85% effective in preventing symptoms and 100% effective and preventing death.

Risk of clotting 7 in 1 million for 18-49 y/o.

Risk of clotting 0.9 in 1 million for > 50 y/o. 

https://www.cidrap.umn.edu/news-perspective/2021/04/acip-opts-lift-pause-johnson-johnson-vaccine